+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-08-08Number of Pages: 157

OTC Consumer Health Products (Powder Form) Market - (Indication- Skin Care, Nutritional Supplements, Oral Care, Wound Care Management, and Gastrointestinal; Distribution Channel - Hospital Pharmacy, Independent Pharmacies and Retail Stores, Hypermarkets and Supermarkets, and Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Global OTC Consumer Health Products (Powder Form) Market: Snapshot

The global market for over-the-counter health products of powder form is projected to experience incremented demand at a CAGR of 3.6% during the forecast period of 2017 to 2025, which is primarily a reflection of growing awareness among the consumers regarding the prevalence of lifestyle diseases. In addition to that, escalating percentage of geriatric population, increasing disposable income, deep penetration of social media, and fitness trends are augmenting the demand in the global OTC consumer health products market. On the other hand, adverse effects of some of the supplements, the lack of valid literature, and counterfeit pharmaceuticals are hindering the market from attaining its true potential. The report estimates the global OTC consumer health products market to be worth US$40.6 bn by the end of the forecast period, which is 2025.

Nutritional Supplements Emerge as Leading Indication Segment

Based on indication, this TMR report segments the global OTC consumer health products market into skin care products, oral care products, nutritional supplements, gastrointestinal products, and wound care management products. In 2016, the nutritional supplements segment served the maximum demand, and is expected to remain most fruitful aspect of the market throughout the forecast period, which is primarily attributed to the growing demand for vitamins and dietary supplements and the sports nutrition products. The report observes that health conscience is increasing among the urban population as a result of changing lifestyle, growing percentage of geriatric population, increasing disposable income, and widespread penetration of social media. On the other hand, the gastrointestinal products segment is expected to sustain its position as second most important segment, as a result of increasing heartburns.

otc consumer health products market

North America to Sustain Position as Most Profitable Region

Out of five major regions evaluated by this report: North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa, the OTC consumer health products market earns maximum demand from North America, which houses two developed countries in the U.S. and Canada. In the near future, North America is expected to maintain its leading position, as a result of high adoption rate of OTC products, changing lifestyle choices, growing demand for healthier options, and escalating geriatric population. In addition to that, as a number of leading players have headquarters in the U.S., strategic acquisitions is expected to reshape the competitive landscape of OTC consumer health products market in North America.

Europe, currently, is the second most lucrative region, with Germany as the leading revenue generating country, although vastly populated region of Asia Pacific is projected to increment the demand for OTC consumer health products market at most robust CAGR during the forecast period of 2017 to 2025. In the near future, two of the most promising emerging economies, India and China, are expected to turn Asia Pacific into a goldmine for the vendors operating in the global OTC consumer health products market.

Some of the key companies currently operating in the global market for over-the-counter consumer health products of power form market are: Pfizer, Inc., Piramal Enterprises Ltd., Abbott Laboratories, Bayer AG, Sun Pharmaceuticals Ltd., GlaxosmithKline plc, Johnson & Johnson, Ipsen, Sanofi S.A., American Health, and Glenmark Pharmaceuticals Ltd. In the near future, development of new products that have fewer to no side effects, imparting awareness via social media and aggressive marketing, and geographical expansion is expected to be the common strategies by the key companies to expand their horizon and cope up with the intense competition.

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights 

2. Assumptions and Research Methodology

3. Executive Summary

4. Market Overview
     4.1. Introduction
            4.1.1. Product Type Definition
            4.1.2. Industry Evolution / Developments 
     4.2. Overview
     4.3. Market Dynamics 
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunities
            4.3.4. Trends
     4.4. Global OTC Consumer Health Products (Powder Form) Analysis and Forecasts,2015–2025 
     4.5. Market Outlook
     4.6. Porter's Five Forces Analysis
     4.7. Value Chain Analysis
     4.8. Regulatory Scenario
     4.9. Factors influencing Rx to OTC Switch

5. Global OTC Consumer Health Products (Powder Form) Market Analysis and Forecasts, By Indication
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Market Value Forecast By Indication, 2015–2025 
            5.3.1. Skin Care products 
            5.3.2. Nutritional Supplement Products
            5.3.3. Oral Care Products
            5.3.4. Wound Care Management Products
            5.3.5. Gastrointestinal Products
            5.3.6. Others
     5.4. Market Attractiveness, By Indication 

6. Global OTC Consumer Health Products (Powder Form) Market Analysis and Forecasts, By Distribution Channel  
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Market Value Forecast By Distribution Channel, 2015–2025
            6.3.1. Hospital Pharmacy
            6.3.2. Independent Pharmacies and Retail Stores
            6.3.3. Hypermarkets & Supermarkets
            6.3.4. Online Sales
            6.3.5. Others
     6.4. Market Attractiveness By Distribution Channel

7. Global OTC Consumer Health Products (Powder Form) Market Analysis and Forecasts, By Region 
     7.1. Introduction & Definition 
     7.2. Key Findings / Developments 
     7.3. Market Size (US$ Mn) Forecast, By Region 
            7.3.1. North America
            7.3.2. Europe
            7.3.3. Asia Pacific 
            7.3.4. Latin America
            7.3.5. Middle East & Africa
     7.4. Market Attractiveness By Region

8. North America OTC Consumer Health Products (Powder Form) Market Analysis and Forecast
     8.1. Introduction
            8.1.1. Key Findings
     8.2. Market Value Forecast By Country, 2015-2025
            8.2.1. U.S.
            8.2.2. Canada
     8.3. Market Size (US$ Mn) Forecast, By Indication
            8.3.1. Skin Care products 
            8.3.2. Nutritional Supplement Products
            8.3.3. Oral Care Products
            8.3.4. Wound Care Management Products
            8.3.5. Gastrointestinal Products
            8.3.6. Others
     8.4. Market Size (US$ Mn) Forecast, By Distribution Channel 
            8.4.1. Hospital Pharmacy
            8.4.2. Independent Pharmacies and Retail Stores
            8.4.3. Hypermarkets & Supermarkets
            8.4.4. Online Sales
            8.4.5. Others
     8.5. Market Attractiveness Analysis
            8.5.1. By Country
            8.5.2. By Indication
            8.5.3. By Distribution Channel

9. Europe OTC Consumer Health Products (Powder Form) Market Analysis and Forecast
     9.1. Introduction
            9.1.1. Key Findings
     9.2. Market Value Forecast By Country, 2015-2025
            9.2.1. U.K.
            9.2.2. Germany
            9.2.3. France
            9.2.4. Italy
            9.2.5. Spain
            9.2.6. Russia
            9.2.7. Rest of Europe
     9.3. Market Size (US$ Mn) Forecast, By Indication
            9.3.1. Skin Care products 
            9.3.2. Nutritional Supplement Products
            9.3.3. Oral Care Products
            9.3.4. Wound Care Management Products
            9.3.5. Gastrointestinal Products
            9.3.6. Others
            9.3.7. Market Size (US$ Mn) Forecast, By Distribution Channel 
            9.3.8. Hospital Pharmacy
            9.3.9. Independent Pharmacies and Retail Stores
            9.3.10. Hypermarkets & Supermarkets
            9.3.11. Online Sales
            9.3.12. Others
     9.4. Market Attractiveness Analysis
            9.4.1. By Country
            9.4.2. By Indication
            9.4.3. By Distribution Channel

10. Asia Pacific OTC Consumer Health Products (Powder Form) Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
            10.1.2. Key Trends
     10.2. Market Value Forecast By Country, 2015-2025
            10.2.1. India
            10.2.2. China
            10.2.3. Japan
            10.2.4. Australia & New Zealand
            10.2.5. Rest of Asia Pacific 
     10.3. Market Size (US$ Mn) Forecast, By Indication
            10.3.1. Skin Care products 
            10.3.2. Nutritional Supplement Products
            10.3.3. Oral Care Products
            10.3.4. Wound Care Management Products
            10.3.5. Gastrointestinal Products
            10.3.6. Others
     10.4. Market Size (US$ Mn) Forecast, By Distribution Channel 
            10.4.1. Hospital Pharmacy
            10.4.2. Independent Pharmacies and Retail Stores
            10.4.3. Hypermarkets & Supermarkets
            10.4.4. Online Sales
            10.4.5. Others
     10.5. Market Attractiveness Analysis
            10.5.1. By Country
            10.5.2. By Indication
            10.5.3. By Distribution Channel

11. Latin America OTC Consumer Health Products (Powder Form) Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
     11.2. Market Value Forecast By Country, 2015-2025
            11.2.1. Brazil
            11.2.2. Mexico
            11.2.3. Rest of Latin America
     11.3. Market Size (US$ Mn) Forecast, By Indication
            11.3.1. Skin Care products 
            11.3.2. Nutritional Supplement Products
            11.3.3. Oral Care Products
            11.3.4. Wound Care Management Products
            11.3.5. Gastrointestinal Products
            11.3.6. Others
     11.4. Market Size (US$ Mn) Forecast, By Distribution Channel 
            11.4.1. Hospital Pharmacy
            11.4.2. Independent Pharmacies and Retail Stores
            11.4.3. Hypermarkets & Supermarkets
            11.4.4. Online Sales
            11.4.5. Others
     11.5. Market Attractiveness Analysis
            11.5.1. By Country
            11.5.2. By Indication
            11.5.3. By Distribution Channel

12. Middle East & Africa OTC Consumer Health Products (Powder Form) Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
            12.1.2. Key Trends
     12.2. Market Value Forecast By Country, 2015-2025
            12.2.1. GCC Countries
            12.2.2. South Africa 
            12.2.3. Rest of Middle East & Africa
     12.3. Market Size (US$ Mn) Forecast, By Indication
            12.3.1. Skin Care products 
            12.3.2. Nutritional Supplement Products
            12.3.3. Oral Care Products
            12.3.4. Wound Care Management Products
            12.3.5. Gastrointestinal Products
            12.3.6. Others
     12.4. Market Size (US$ Mn) Forecast, By Distribution Channel 
            12.4.1. Hospital Pharmacy
            12.4.2. Independent Pharmacies and Retail Stores
            12.4.3. Hypermarkets & Supermarkets
            12.4.4. Online Sales
            12.4.5. Others
     12.5. Market Attractiveness Analysis
            12.5.1. By Country
            12.5.2. By Indication
            12.5.3. By Distribution Channel

13. Competition Landscape
     13.1. Market Player – Competition Matrix (By Tier and Size of companies)
     13.2. Market Share Analysis By Company (2016)
     13.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            13.3.1. Pfizer, Inc.
                      13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.1.2. Business Overview
                      13.3.1.3. Product Portfolio 
                      13.3.1.4. Financial Overview 
                      13.3.1.5. SWOT Analysis 
                      13.3.1.6. Strategic overview
            13.3.2. GlaxoSmithKline plc 
                      13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.2.2. Business Overview
                      13.3.2.3. Product Portfolio 
                      13.3.2.4. Financial Overview 
                      13.3.2.5. SWOT Analysis 
                      13.3.2.6. Strategic overview
            13.3.3. Johnson & Johnson 
                      13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.3.2. Business Overview
                      13.3.3.3. Product Portfolio 
                      13.3.3.4. Financial Overview 
                      13.3.3.5. SWOT Analysis 
                      13.3.3.6. Strategic overview
            13.3.4. Sun Pharmaceuticals Ltd. 
                      13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.4.2. Business Overview
                      13.3.4.3. Product Portfolio 
                      13.3.4.4. Financial Overview 
                      13.3.4.5. SWOT Analysis 
                      13.3.4.6. Strategic overview
            13.3.5. Piramal Enterprises Ltd.
                      13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.5.2. Business Overview
                      13.3.5.3. Product Portfolio 
                      13.3.5.4. Financial Overview 
                      13.3.5.5. SWOT Analysis 
                      13.3.5.6. Strategic overview
            13.3.6. Abbott Laboratories
                      13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.6.2. Business Overview
                      13.3.6.3. Product Portfolio 
                      13.3.6.4. Financial Overview 
                      13.3.6.5. SWOT Analysis 
                      13.3.6.6. Strategic overview
            13.3.7. Ipsen  
                      13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.7.2. Business Overview
                      13.3.7.3. Product Portfolio 
                      13.3.7.4. Financial Overview 
                      13.3.7.5. SWOT Analysis 
                      13.3.7.6. Strategic overview
            13.3.8. Bayer AG
                      13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.8.2. Business Overview
                      13.3.8.3. Product Portfolio 
                      13.3.8.4. Financial Overview 
                      13.3.8.5. SWOT Analysis 
                      13.3.8.6. Strategic overview
            13.3.9. Sanofi S.A 
                      13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.9.2. Business Overview
                      13.3.9.3. Product Portfolio 
                      13.3.9.4. Financial Overview 
                      13.3.9.5. SWOT Analysis 
                      13.3.9.6. Strategic overview
            13.3.10. Glenmark Pharmaceuticals Limited
                      13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.10.2. Business Overview
                      13.3.10.3. Product Portfolio 
                      13.3.10.4. Financial Overview 
                      13.3.10.5. SWOT Analysis 
                      13.3.10.6. Strategic overview
            13.3.11. American Health, Inc. 
                      13.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
                      13.3.11.2. Business Overview
                      13.3.11.3. Product Portfolio 
                      13.3.11.4. Financial Overview 
                      13.3.11.5. SWOT Analysis 
                      13.3.11.6. Strategic overview

List of Figures

Figure 01: Global OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%), and Forecast, 2017–2025
Figure 02: Market Value Share By Indication (2017)
Figure 03: Market Value Share By Distribution Channel (2017)
Figure 04: Market Value Share By Region (2017)
Figure 05: Porter's Five Force Analysis
Figure 06: Value Chain Analysis
Figure 07: Factors considered for successful Rx to OTC switch
Figure 08: OTC Drug approval process – U.S.
Figure 09: OTC Drug approval process in Japan
Figure 10: Global OTC Consumer Health Products (powder form) Market Value Share Analysis, by Indication, 2016 and 2025
Figure 11: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Skin Care, 2015–2025
Figure 12: Global OTC Consumer Health Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Nutritional Supplements, 2015–2025
Figure 13: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Oral Care, 2015–2025
Figure 14: Global OTC Consumer Health Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Wound Care Management, 2015–2025
Figure 15: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Gastrointestinal products, 2015–2025
Figure 16: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Other products, 2015–2025
Figure 17: Global OTC Consumer Health Products (powder form) Market Attractiveness, by Indication
Figure 18: Global OTC Consumer Health Products (powder form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 19: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Hospital Pharmacy, 2015–2025
Figure 20: Global OTC Consumer Health Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Independent Pharmacies & Retail Stores, 2015–2025
Figure 21: Global OTC Consumer Health Products Market Revenue (US$ Mn), and Y-o-Y Growth (%), by Hypermarkets & Supermarkets, 2015–2025
Figure 22: Global OTC Consumer Health Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Sales, 2015–2025
Figure 23: Global Others Market Revenue (US$ Mn), and Y-o-Y Growth (%), 2015–2025
Figure 24: Global OTC Consumer Health Products (powder form) Market Attractiveness, by Distribution Channel
Figure 25: Global OTC Consumer Health Products (powder form) Market Revenue, US$ Mn, 2015–2025
Figure 26: Global OTC Consumer Health Products (powder form) Market Value Share Analysis, by Region, 2016 and 2025
Figure 27: Global OTC Consumer Health Products (powder form) Market Attractiveness, by Region
Figure 28: North America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 29: North America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
Figure 30: North America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
Figure 31: North America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
Figure 32: North America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 33: North America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
Figure 34: North America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
Figure 35: Europe OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 36: Europe OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
Figure 37: Europe OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
Figure 38: Europe OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
Figure 39: Europe OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 40: Europe OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
Figure 41: Europe OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
Figure 42: Asia Pacific OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 43: Asia Pacific OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
Figure 44: Asia Pacific OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
Figure 45: Asia Pacific OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
Figure 46: Asia Pacific OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 47: Asia Pacific OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
Figure 48: Asia Pacific OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
Figure 49: Latin America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 50: Latin America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
Figure 51: Latin America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
Figure 52: Latin America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
Figure 53: Latin America OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel,
Figure 54: Latin America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
Figure 55: Latin America OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
Figure 56: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 57: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Attractiveness, by Country
Figure 58: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Country, 2016 and 2025
Figure 59: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Indication, 2016 and 2025
Figure 60: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 61: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Attractiveness, by Indication
Figure 62: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Attractiveness, by Distribution Channel
Figure 63: Global OTC Consumer Health Products (powder form) Market Share Analysis, by Company (2016)
Figure 64: Pfizer, Inc., Breakdown of Net Sales (2016), by Region
Figure 65: Pfizer, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 66: GlaxoSmithKline plc, Breakdown of Net Sales, by Segment, 2016
Figure 67: GlaxoSmithKline plc, Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2016
Figure 68: Johnson & Johnson, Breakdown of Net Sales, by Region, 2016
Figure 69: Johnson & Johnson, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 70: Sun Pharmaceuticals Ltd., Breakdown of Net Sales, by Region, 2016
Figure 71: Sun Pharmaceuticals Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 72: Piramal Enterprises Ltd., Breakdown of Net Sales, by Business Segment, 2016
Figure 73: Piramal Enterprises Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 74: Abbott Laboratories, Breakdown of Net Sales (%Share), by Region (2016)
Figure 75: Abbott Laboratories, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 76: Ipsen, Breakdown of Net Sales, by Segment, 2016
Figure 77: Ipsen, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 78: Bayer AG, Breakdown of Net Sales (%), by Region (2016)
Figure 79: Bayer AG, Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2016
Figure 80: Sanofi S.A, Breakdown of Net Sales, by Region, 2016
Figure 81: Sanofi S.A, Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2016
Figure 82: Glenmark Pharmaceuticals Limited, Breakdown of Net Sales, by Region, 2016
Figure 83: Glenmark Pharmaceuticals Limited, Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2016

List of Tables

Table 01: Global OTC Consumer Health Products (powder form) Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 02: Global OTC Consumer Health Products (powder form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 03: Global OTC Consumer Health Products (powder form) Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 04: North America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 05: North America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 06: North America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 07: Europe OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 08: Europe OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 09: Europe OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 10: Asia Pacific OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 11: Asia Pacific OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 12: Asia Pacific OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 13: Latin America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 14: Latin America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication,
Table 15: Latin America OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 16: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 17: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Indication, 2015–2025
Table 18: Middle East & Africa OTC Consumer Health Products (Powder Form) Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025

Global OTC Consumer Health Products (Powder Form) Market: Overview

OTC consumer health products (powder form) include the OTC pharmaceutical products which can be defined as the drugs which can be purchased by the customers without the physician’s prescription. In addition, OTC consumer health products include nutritional supplements and sports nutrition products, among others. The market for OTC consumer health products (powder form) has been segmented on the basis of indication and distribution channel. On the basis of indication, the market has been segmented into skin care products, nutritional supplement products, oral care products, wound care management products, gastrointestinal products and others. On the basis of distribution channel, the market has been segmented into hospital pharmacy, independent pharmacies and retail stores, hypermarkets and supermarkets and others.

Global OTC Consumer Health Products (Powder Form) Market: Research Methodology

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of OTC consumer health products (powder form) instruments and consumables in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for each products and end-user. In addition, the report provides estimated market size in terms of US$ Mn for various geographic regions for the period 2015 to 2025, considering the macro and micro environmental factors. The revenue generated from each product was calculated by considering their launch date in the market, customer acceptance, volume sales, price of the product, trends in industry, end user trend, and adoption rate across all the geographies.

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on product, end-user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the molecular diagnostics market in the current and future scenario.

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Global OTC Consumer Health Products (Powder Form) Market: Competitive Landscape

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the OTC consumer health products (powder form) market report are Pfizer, Inc., GlaxosmithKline plc, Johnson & Johnson, Sun Pharmaceuticals Ltd., Piramal Enterprises Ltd., Abbott Laboratories, Ipsen, Bayer AG, Sanofi S.A., Glenmark Pharmaceuticals Limited, and American Health, among others.

The OTC Consumer Health Products (Powder Form) Market has been segmented as follows:

  • OTC Consumer Health Products (Powder Form) Market, by Indication, Revenue (US$ Mn), 2015-2025
    • Skin Care Products
    • Nutritional Supplements
    • Oral Care Products
    • Wound Care Management Products
    • Gastrointestinal Products
    • Others
  • OTC Consumer Health Products (Powder Form) Market, by Distribution Channel, Revenue (US$ Mn), 2015-2025
    • Hospital Pharmacy
    • Independent Pharmacies and Retail Stores
    • Hypermarkets and Supermarkets
    • Online Sales
    • Others
  • OTC Consumer Health Products (Powder Form) Market, by Region, Revenue (US$ Mn) 2015-2025
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • France
      • Germany
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • India
      • China
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of MEA


 
 
Back To Top